Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
JCO Oncology Practice|June 27, 2025
Association of Cannabis Use With Guideline-Recommended Cancer Screenings: Results From a National Health Behaviors SurveyFilippo Dagnino, Klara K Pohl, Zhiyu Qian, et al.
American Journal of Preventive Medicine|December 20, 2025
The Impact of Adverse Childhood Experiences on Cancer Screening: Findings from the Behavioral Risk Factor Surveillance SystemKlara K Pohl, Hanna Zurl, Andrea Piccolini, et al.
International Urology and Nephrology|September 9, 2025
Medicolegal landscape of prostate cancer ablative therapy: a national legal database analysis of malpractice claims (1970-2024)Boyuan Xiao, Zhiyu Qian, Andrea Piccolini, et al.
BMC Medicine|November 6, 2025
Rising metastatic prostate cancer rates but narrowing racial gapHanna Zurl, Zhiyu Qian, Klara K Pohl, et al.
European Urology Focus|August 2, 2025
Estimating the Carbon Emissions of a Single Prostate-specific Antigen Test: Results from a Cradle-to-grave Life Cycle AssessmentHanna Zurl, Stephan M Korn, Klara K Pohl, et al.
Urology|December 19, 2025
Prostate Biopsy and Malpractice: Analysis of a National Legal Database from 1995 to 2025Boyuan Xiao, Zhiyu Qian, Sydney L Look-Why, et al.
Journal of Endourology|November 18, 2025
Claims-Based Analysis of National Utilization Patterns and Regional Variability of Prostate Cancer Ablative Therapies: A Medicare StudyStephan M Korn, Zhiyu Qian, Hanna Zurl, et al.
JAMA Network Open|December 3, 2025
Travel Time to Treating Facility and Mortality in Men With Prostate CancerStephan M Korn, Filippo Dagnino, Danesha Daniels, et al.
The Prostate|July 30, 2025
Racial Disparities in the Use of MRI and PET Scan Among Medicare Beneficiaries With Prostate CancerHanna Zurl, Klara K Pohl, Stephan M Korn, et al.
JNCI Cancer Spectrum|May 16, 2025
Disparities in Tissue-based Biomarker Testing Among U.S. Medicare Beneficiaries with Prostate CancerStephan M Korn, Zhiyu Qian, Hanna Zurl, et al.
Pageof 2